Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Boswellia and Saccharomyces Boulardii are closely matched across evidence, studies, and safety.
Verdict
Likely helps
7 of 7 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
13 of 15 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Boswellia and Saccharomyces Boulardii have evidence — compare verdict strength side-by-side.
300-500mg standardized extract (30-40% AKBA), 2-3x daily
With meals containing fat
Standardized extract (30-40% AKBA or 65% boswellic acids)
250-500mg (5-10 billion CFU) daily
With or without food, At least 2 hours away from antifungals
Capsules (lyophilized)
4-8 weeks
4-8 weeks
2-4 weeks
During use
1-3 days
1-2 weeks
Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis
Nutrients (2025) · Meta analysis · n=4599
Bayesian rankings indicated Boswellia had the highest probability of being most effective for pain and stiffness, with krill oil and curcumin showing potential for function improvement.
Oral herbal medicines marketed in Brazil for the treatment of osteoarthritis: A systematic review and meta-analysis
Phytotherapy research : PTR (2017) · Meta analysis · n=1741
Z. officinale showed improvement of pain over placebo.
Oral herbal therapies for treating osteoarthritis
The Cochrane database of systematic reviews (2014) · Meta analysis · n=5980
Seventeen studies of confirmatory design (sample and effect sizes pre-specified) were mostly at moderate risk of bias.
Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis
Frontiers in cellular and infection microbiology (2025) · Meta analysis · n=5036
S. boulardii supplementation in traditional eradication therapy significantly improves the H. pylori eradication rate and reduces the total adverse effects and incidence of diarrhea, bloating, constipation, and nausea.
Probiotics for treating acute infectious diarrhoea
The Cochrane database of systematic reviews (2020) · Meta analysis · n=12127
Effect size was similar in the sensitivity analysis and marked heterogeneity persisted.
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes
Gut microbes (2024) · Meta analysis · n=2871
This review aims to analyze available evidence from human-controlled trials to determine the effect size of probiotic interventions in decolonizing AMR pathogenic bacteria from the gut.
Based on multiple meta-analyses showing pain reduction in osteoarthritis. Effects may vary significantly by extract standardization (AKBA content) and bioavailability enhancement. Studies primarily used 30-40% AKBA extracts.
Based on multiple meta-analyses showing 1.1-1.6 day reduction in diarrhea duration. Effect size appears to plateau at standard therapeutic doses. Limited data on doses above 20 billion CFU.
AI-estimated from published studies. Interpret as directional guidance.
Both Boswellia and Saccharomyces Boulardii are closely matched — the best choice depends on your specific health goals.
For reduce inflammation, Boswellia has a higher relevance score (95 vs 90).
No known interactions between Boswellia and Saccharomyces Boulardii have been documented in our database. However, always consult a healthcare provider before combining supplements.